(2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide-D4; [2S-(2?,3?,5?)]-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4,4-Dioxide-D4; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid deriv. 1H-1,2,3-Triazole-D4; CL 298741-D4; Tazobactam-D4; YTR 830H-D4;
Tazobactam-d4 is a fully characterized chemical compound used as a reference standard of API Tazobactam. The standard offered is compliant with regulatory guidelines. Tazobactam-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
